Adiponectin levels were associated with increased likelihood of metabolic health improvements and lower risk for diabetes across 6 years.

The first piece of the puzzle is ready, and it concerns a hormone called adiponectin. This hormone regulates the body's ...

Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

Women with early menopause are likely to have a higher risk of heart failure, reveals a study published in the Menopause.The mechanisms through which menopausal age influences heart failure ...

Obesity is a growing global health issue linked to a higher risk of many cancers. A detailed review published in Frontiers of ...